CABA Prices $150M Offering at $2.90/Share, Led by Bain Capital, Eli Lilly; 51.7M Shares Sold by Company
Cabaletta Bio, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $3.67
+8.4% in 1d after detection
Post-detection moves
1h
—
1d
+8.4%
3d
+4.4%
7d
-6.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS